Ozmosi | Eplivanserin Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Eplivanserin

Alternative Names: eplivanserin
Clinical Status: Inactive
Latest Update: 2016-03-07
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: 5-HT2A Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: Europe
Company CEO: Paul Hudson
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Insomnia

Phase 2: Myofascial Pain Syndromes|Parasomnias|Chronic Pain|Fibromyalgia

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

2014-004644-35

2014-004644-35

P1

Terminated

Insomnia

2013-02-25

2025-06-29

Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status

NCT00913614

PKiDs

P1

Completed

Insomnia

2009-12-01

2024-10-16

Primary Endpoints|Treatments

NCT00313885

ACT5400

P2

Completed

Fibromyalgia|Myofascial Pain Syndromes|Chronic Pain|Parasomnias

2005-06-01

2024-10-16

Primary Endpoints

2008-003791-22

ECLIPSE

P3

Completed

Insomnia

2009-06-05

2022-03-12

Treatments

NCT00805350

ECLIPSE

P3

Completed

Insomnia

2009-06-01

2024-10-16

Primary Endpoints|Treatments

2007-003822-28

DREAMS

P3

Completed

Insomnia

2009-03-06

2022-03-12

Treatments

NCT00679900

DREAMS

P3

Completed

Insomnia

2009-03-01

2024-10-16

Primary Endpoints|Treatments

2005-003082-16

EPLILONG

P3

Completed

Insomnia

2008-09-10

2022-03-12

Treatments

NCT00253968

GEMS

P3

Completed

Insomnia

2008-01-01

2024-10-16

Primary Endpoints|Treatments

NCT00253903

EPLILONG

P3

Completed

Insomnia

2007-11-01

2024-10-16

Primary Endpoints|Treatments

2005-003080-23

GEMS

P3

Completed

Insomnia

2007-10-16

2022-03-12

Treatments

NCT00308503

EPOCH

P3

Completed

Insomnia

2007-08-01

2024-10-16

Primary Endpoints

Recent News Events

Date

Type

Title